HC Pharma

Active

Private limited companyfounded 1961active for 65 yearsKapellestraat 55, 9220 Hamme (Vl.), BelgiumKBO/BCE: BE 0405.023.993

From the official registers: KBO 47 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

The computed 12-month bankruptcy probability of HC Pharma is 3.2% (moderate). The 2025 annual accounts show negative equity (-€992,548) and a net result of -€235,534. Equity is growing by about 4.7% per year across the filed financial years. Its solvency ranks better than 9% of 12,737 sector peers (NACE 47, financial year 2025). The company has been active since 1961 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

HC PharmaActiveChecked score 48/100

Risk analysis Report Compare

Directors

4 directors, 3 in day-to-day management, last change in 2026

Board 4

ALEXO

Chair of the board · appointed in the act of 02-12-2022 · Director · since 01-09-2022 · Private limited company · permanent representative: Olivier Delaere · in the 2025 annual accounts, filed on 12-05-2026

Current

LOUWAGIE CONSULTING

Director · since 01-07-2022 · Private limited company · in the 2025 annual accounts, filed on 12-05-2026

Current

BV KST Pharma

Director · appointed in the act of 24-07-2026 · Legal entity · permanent representative: Koen Straetmans

Current

Louwagie Gilles

Director · appointed in the act of 27-09-2022 · Legal entity

Current

Day-to-day management 3

LOUWAGIE CONSULTING

Managing director · appointed in the act of 27-09-2022 · Private limited company

Current

BV SODIAP

Managing director · in office according to the act of 24-07-2026 · Legal entity · permanent representative: Tom Goderis

Current

Louwagie Gilles

Managing director · appointed in the act of 27-09-2022 · Legal entity

Current

Permanent representatives 3

Olivier Delaere

Permanent representative · appointed in the act of 02-12-2022 · for ALEXO

Current

Koen Straetmans

Permanent representative · appointed in the act of 24-07-2026 · for BV KST Pharma

Current

Tom Goderis

Permanent representative · in office according to the act of 24-07-2026 · for BV SODIAP

Current

Office holders in the KBO →

Mandate history

6 people, 5 in office

All 6 In office 5 Ended 1

Board
Day-to-day management
began earlier

Mandates per person, with start and end dates
Name	Functions and periods
LOUWAGIE CONSULTING	Director, from 01-07-2022 to date Managing director, appointed in the act of 27-09-2022, still in office
ALEXO	Chair of the board, from 01-09-2022 to date Director, from 01-09-2022 to 24-07-2026
Louwagie Gilles	Director, appointed in the act of 27-09-2022, still in office Managing director, appointed in the act of 27-09-2022, still in office
BV KST Pharma	Director, appointed in the act of 24-07-2026, still in office
BV SODIAP	Managing director, since before 24-07-2026
ARISTO	Director, until 31-08-2022

See the board, name and registered office on a given date →

Owners and capital

Owners

1 owner

Chain of control

PHARMACIE BIA 100%
FEBELCO 100%
SODIAP 100%
HC Pharma

Owners 1

SODIAPparent
Sourceaccounts SODIAP 2025

100%